Neogen stock holds steady as latest quarter tops earnings expectations
Published on 08/31/2026 at 07:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Neogen Corporation (ISIN US6404911066) stock is trading in the low-teens in late August 2026 after the company reported a quarterly earnings beat with essentially flat revenue year over year as of its latest results released July 30, 2026.
Latest earnings beat with flat revenue
In its most recent reported quarter, Neogen posted earnings per share of $0.09, ahead of the consensus estimate of $0.06, giving investors a modest upside surprise on the bottom line for the period ending in mid-2026.
Quarterly revenue came in at $225.30 million, compared with analyst expectations of $212.35 million, so sales exceeded forecasts even though they were down 0.1 percent versus the same quarter a year earlier.
The company reported a positive return on equity of 2.78 percent for the quarter, while its net margin remained slightly negative at 0.91 percent, illustrating that profitability metrics are improving but not yet fully normalized.
In the comparable quarter of the prior year, Neogen recorded a much larger loss with earnings per share of -$2.82, highlighting how the latest $0.09 EPS result marks a sharp swing back toward profitability.
Equities research analysts currently forecast that Neogen will deliver full-year EPS of 0.27 for the current fiscal year, indicating expectations for continued progress in earnings through the remainder of 2026.
Stock trades in the low-teens with multi-billion market cap
As of the recent trading session dated August 30, 2026, Neogen shares were quoted at $11.66, placing the stock in the lower-teens range on the Nasdaq and giving investors a clear reference point for current valuation levels.
On that same session, the stock traded between an intraday low of $11.43 and a high of $11.79, with the $11.66 quote sitting 2.0 percent above the low and 1.1 percent below the high, suggesting a relatively tight trading range without major volatility.
Looking at longer-term price context, the company’s shares currently stand between a 12-month low of $4.90 and a 12-month high of $12.85, so the late-August price is notably above the bottom of the range and moderately below the peak.
A market-cap overview dated August 30, 2026 shows Neogen valued at $2.54 billion, giving the company a substantial mid-cap profile within the broader agritech and food safety space, even as investors watch how earnings growth develops.
On that valuation snapshot, a separate quote source lists Neogen’s market capitalization at $2.55 billion, a minor difference that still describes the company squarely in the multi-billion-dollar category.
Margin recovery and year-over-year comparison
The latest quarter’s revenue of $225.30 million being down 0.1 percent year over year means Neogen is essentially maintaining its sales base while focusing on improving margins and earnings.
The swing from a prior-year quarterly EPS of -$2.82 to the most recent $0.09 underscores a significant improvement in profitability, even if net margin is still slightly negative at 0.91 percent.
Return on equity of 2.78 percent in the latest period indicates that the company is again generating positive returns for shareholders after the prior-year loss, though the level of ROE remains modest compared with mature peers in healthcare diagnostics and food safety.
Analyst projections calling for full-year EPS of 0.27 suggest that, if Neogen can sustain its margin gains and avoid renewed one-off charges, its earnings trajectory could be meaningfully different from the loss that characterized the comparable quarter in the previous year.
Given the marginal decline in revenue and the move to positive EPS, investors are likely to focus on whether upcoming quarters can deliver both top-line growth and continued margin improvement to support the current valuation.
Representative product in food safety and diagnostics
Neogen is widely known for its portfolio of food safety and animal health products, including diagnostic tests and related technologies designed to help producers detect contaminants and manage herd health, which supports recurring demand for its testing solutions.
Shares hold in the low-teens
With Neogen stock trading at $11.66 as of August 30, 2026 on the Nasdaq and the company’s market capitalization around $2.5 billion, investors have a clear picture of a mid-cap name that has recently turned quarterly earnings positive while revenue remains flat.
Fact box
Company: Neogen Corporation
ISIN: US6404911066
Ticker: NEOG
Exchange: Nasdaq
Price (as of August 30, 2026): $11.66 USD
Market cap: $2.54 billion (as of August 30, 2026)
Sector / Industry: Healthcare diagnostics and food safety
Index membership: Not in major US large-cap indices
